market valuation is not an exact science and most of the times does not have much logic in it. Countless examples to research where loss making companies are evaluated in the billions after many years of increased losses having 40-50x revenue valuations... ref AT1, on the increased production by the end of this CY + upcoming FDA approvals + real possibility of positive earnings this FY, I'd argue that AT1 is undervalued ... but any other argument is as good as mine on the casino
market valuation is not an exact science and most of the times...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
